Michel M C
Medizinische Klinik Nephrologie, Universitätsklinikum Essen, FRG.
Trends Pharmacol Sci. 1991 Oct;12(10):389-94. doi: 10.1016/0165-6147(91)90610-5.
Neuropeptide Y (NPY) can elicit numerous physiological responses by activating specific pre- and postsynaptic receptors. Different orders of potency for agonists in various model systems suggest that there are multiple subtypes of NPY receptors, described here by Martin Michel, but their pharmacological definition remains tentative, awaiting development of specific antagonists and receptor cloning studies. The coupling of NPY receptors to various signal transduction mechanisms is also reviewed, including inhibition of adenylyl cyclase and stimulation or inhibition of increases in intracellular Ca2+, but a link between individual NPY receptor subtypes and specific signal transduction pathways has not been established.
神经肽Y(NPY)可通过激活特定的突触前和突触后受体引发多种生理反应。在各种模型系统中,激动剂的效价顺序不同,这表明存在多种NPY受体亚型,Martin Michel在此进行了描述,但它们的药理学定义仍不确定,有待特异性拮抗剂的开发和受体克隆研究。本文还综述了NPY受体与各种信号转导机制的偶联,包括对腺苷酸环化酶的抑制以及对细胞内Ca2+升高的刺激或抑制,但尚未确定单个NPY受体亚型与特定信号转导途径之间的联系。